Work

Factors influencing patient treatment selection among bispecific antibodies for relapsed/refractory multiple myeloma (RRMM): A mixed methods study

Year: 2025

Type: conference-abstract

Source: Blood

DOI: 10.1182/blood-2025-2631

Authors: Thomas LeBlanc, Rakesh Popat, C. Kennedy, Josh Coulter, Lewis Kopenhafer, William You, Kathleen Beusterien, David Hughes, Guido Nador, Joseph C Cappelleri, Marco Dibonaventura, Mohsena Sumaya, Patrick Hlavacek

Institutions: Duke University, University College London Hospitals NHS Foundation Trust, Pfizer (United States), Oracle (United States), Pfizer (United Kingdom)

Language: English

Topic: Multiple Myeloma Research and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4417020027

Cites:

Cited by:

Related to: